Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Plaque Psoriasis
Related studies linked through entity extraction aliases.
A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Open-label Study of Subcutaneous Secukinumab to Evaluate Efficacy and Safety in Patients With Plaque Psoriasis Who Had Inadequate Response to Cyclosporine A
- Status
- COMPLETED
- Phase
- PHASE4
DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis
- Status
- TERMINATED
- Phase
- PHASE3
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Long Term Safety Extension Study (CHS-0214-05)
- Status
- COMPLETED
- Phase
- PHASE3
A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 (Dalazatide) in Active Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study
- Status
- COMPLETED
- Phase
- PHASE2
Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE4
Plaque Psoriasis Efficacy and Safety With Secukinumab
- Status
- COMPLETED
- Phase
- PHASE3
A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306)
- Status
- COMPLETED
- Phase
- PHASE3
A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3